Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Hodl-Kühnast Isabel |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Originalarbeit (Zeitschrift)
** Hatzl, S; Posch, F; Schulz, E; Uhl, B; Hodl, I; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Lackner, A; Kleinhappl, B; Moazedi-Fürst, F; Khalil, M; Enzinger, C; Eller, P; Krammer, F; Krause, R; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J; Greinix, H
Altered immune responses to mRNA vaccination against SARS-COV-2 are characterized by an impaired cross-talk between humoral and T-cellular immune compartments in patients with hematologic diseases.
Vaccine. 2025; 63:127666
Doi: 10.1016/j.vaccine.2025.127666
Web of Science
PubMed
FullText
FullText_MUG
** Stenlander, C; Lindahl, H; Wahren-Borgström, E; Geier, CB; Sediva, A; Fevang, B; Milito, C; Varandas, C; Roca-Oporto, C; Pulvirenti, F; Hodl, I; Malkusova, I; Rivière, JG; Litzman, J; Walter, JE; Hanitsch, LG; Neth, O; Kralickova, P; Miller, R; Shaffren, S; Silva, SL; Katzenstein, T; Martelius, T; Steiner, UC; Smith, CIE; Warnatz, K; Bergman, P
Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study.
J Clin Immunol. 2025; 45(1):161
Doi: 10.1007/s10875-025-01962-3
PubMed
FullText
FullText_MUG
2024
Originalarbeit (Zeitschrift)
** Karbiener, M; Kindle, G; Meyts, I; Seppänen, MRJ; Candotti, F; Kamieniak, M; Ilk, R; Kreil, TR; Seidel, MG, , ESID‐COVID, Consortium
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
J Med Virol. 2024; 96(6):e29738
Doi: 10.1002/jmv.29738
Web of Science
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103
Doi: 10.1016/j.micinf.2023.105103
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Reininghaus, EZ; Manchia, M; Dalkner, N; Bonkat, N; Squassina, A; Hodl, I; Vieta, E; Reif, A; Hajek, T; Landén, M; Correll, CU; Scott, J; Etain, B; Rietschel, M; Bergink, V; Martinez-Cengotitabengoa, M; Kessing, LV; Fagiolini, A; Bauer, M; Goodwin, G; Gonzalez-Pinto, A; Kupka, RW; Schulze, TG; Lagerberg, TV; Yildiz, A; Henry, C; Morken, G; Ritter, P; Nieslen, RE; Licht, RW; Bechdolf, A; Andreassen, OA; Fellendorf, FT
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review.
Eur Neuropsychopharmacol. 2022; 54:90-99
Doi: 10.1016/j.euroneuro.2021.09.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Sallegger, C; Hodl, I; Dreo, B; Ihm, VL; Thiel, J; Stradner, M; Fessler, J
DISTURBED CELLULAR IMMUNITY FOLLOWING MRNA VACCINATION AGAINST COVID-19 IN PATIENTS WITH B-CELL DEPLETING THERAPY
ANN RHEUM DIS. 2022; 81: 969-970.-EULAR; Kopenhagen, DENMARK;.
Doi: 10.1136/annrheumdis-2022-eular.4450
[Poster]
Web of Science
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742
Doi: 10.3389/fimmu.2021.803742
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Hodl, I; Bosch, P; Dreo, B; Stradner, MH
Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome.
Front Immunol. 2020; 11: 576200-576200.
Doi: 10.3389/fimmu.2020.576200
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG